XML 25 R13.htm IDEA: XBRL DOCUMENT v3.25.0.1
EQUITY
 3 Months Ended
Dec. 28, 2024
Equity [Abstract]  
EQUITY EQUITY (DEFICIT)
The following tables provide a summary of the changes in equity (deficit) for each of the periods indicated:
 Common Shares and Capital in
Excess of Stated Value		Retained
Earnings		Treasury
Shares		Accumulated Other
Comprehensive Loss		Total
Equity
(Deficit)
Balance at September 30, 2024$362.0 $303.8 $(949.1)$(107.3)$(390.6)
Net income (loss)— (69.5)— — (69.5)
Other comprehensive income (loss)— — — 2.5 2.5 
Share-based compensation31.4 — — — 31.4 
Dividends declared ($0.66 per share)
— (38.5)— — (38.5)
Treasury share purchases— — (15.6)— (15.6)
Treasury share issuances(44.3)— 45.1 — 0.8 
Balance at December 28, 2024$349.1 $195.8 $(919.6)$(104.8)$(479.5)
The sum of the components may not equal due to rounding.
 Common Shares and Capital in
Excess of Stated Value		Retained
Earnings		Treasury
Shares		Accumulated Other
Comprehensive Loss		Total
Equity
(Deficit)
Balance at September 30, 2023$353.1 $490.9 $(998.5)$(112.8)$(267.3)
Net income (loss)— (80.5)— — (80.5)
Other comprehensive income (loss)— — — (8.9)(8.9)
Share-based compensation11.7 — — — 11.7 
Dividends declared ($0.66 per share)
— (38.0)— — (38.0)
Treasury share purchases— — (3.1)— (3.1)
Treasury share issuances(15.2)— 15.9 — 0.7 
Balance at December 30, 2023$349.6 $372.4 $(985.7)$(121.7)$(385.4)
The sum of the components may not equal due to rounding.
Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss (“AOCL”) by component were as follows for each of the periods indicated:
Three Months Ended
Foreign Currency
Translation Adjustments		Net Unrealized Gain (Loss)
On Derivative Instruments		Net Unrealized
Loss On Securities		Pension and Other Post-Retirement
Benefit Adjustments		Accumulated Other
Comprehensive Income (Loss)
Balance at September 30, 2024$(21.3)$4.9 $(14.4)$(76.5)$(107.3)
Other comprehensive income (loss) before reclassifications(5.8)7.7 — — 1.9 
Amounts reclassified from accumulated other comprehensive net income (loss)— (2.3)— 5.8 3.5 
Income tax benefit (expense)— (1.4)— (1.5)(2.9)
Net current period other comprehensive income (loss)(5.8)4.0 — 4.3 2.5 
Balance at December 28, 2024$(27.1)$8.9 $(14.4)$(72.2)$(104.8)
Balance at September 30, 2023$(21.9)$20.1 $(38.6)$(72.4)$(112.8)
Other comprehensive income (loss) before reclassifications3.1 (11.0)(0.9)— (8.8)
Amounts reclassified from accumulated other comprehensive net income (loss)— (2.0)— (2.1)(4.1)
Income tax benefit (expense)— 3.3 — 0.7 4.0 
Net current period other comprehensive income (loss)3.1 (9.7)(0.9)(1.4)(8.9)
Balance at December 30, 2023$(18.8)$10.4 $(39.5)$(73.8)$(121.7)
The sum of the components may not equal due to rounding.
Share-Based Awards
Subsequent to December 28, 2024, the Company awarded performance-based award units, stock options and deferred stock units representing 0.2 million Common Shares to associates and members of the Board of Directors with an estimated grant date fair value of $13.4.
Total share-based compensation was as follows for each of the periods indicated:
Three Months Ended
December 28,
2024		December 30,
2023
Share-based compensation$17.3 $16.0 
Related tax benefit recognized2.6 2.6 
Stock Options
Stock option activity was as follows:
No. of
Options		Wtd. Avg.
Exercise Price		Wtd. Avg.
Remaining Life		Aggregate
Intrinsic Value
Awards outstanding at September 30, 20242,377,672 $65.03 7.5 years
Granted419,885 72.60 
Exercised(4,570)61.31 
Forfeited(139,881)65.31 
Awards outstanding at December 28, 20242,653,106 66.25 7.6 years$25.4 
Exercisable548,227 104.43 3.0 years2.0 
The weighted-average fair value per share of each option granted during the three months ended December 28, 2024 and December 30, 2023 was $22.26 and $15.16, respectively. The total intrinsic value of options exercised during the three months ended December 28, 2024 was not material. There were no options exercised during the three months ended December 30, 2023. As of December 28, 2024, there was $10.6 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options that is expected to be recognized over a weighted-average period of 2.0 years. Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $0.7 and $0.5 for the three months ended December 28, 2024 and December 30, 2023, respectively.
The weighted average assumptions used in the estimation of fair value for awards granted during the three months ended December 28, 2024 are as follows:
Expected volatility39.6 %
Risk-free interest rate4.2 %
Expected dividend yield3.3 %
Expected life6.1 years
Restricted share-based awards
Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows: 
No. of
Units		Wtd. Avg. Grant Date
Fair Value per Unit
Awards outstanding at September 30, 2024766,384 $68.54 
Granted281,950 75.36 
Vested(521,023)63.62 
Forfeited(10,741)68.38 
Awards outstanding at December 28, 2024516,570 77.23 
The weighted-average grant-date fair value of restricted share-based awards granted during the three months ended December 28, 2024 and December 30, 2023 was $75.36 and $48.79 per share, respectively. As of December 28, 2024, there was $7.6 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share-based awards that is expected to be recognized over a weighted-average period of 1.8 years. The total fair value of restricted share-based awards vested during the three months ended December 28, 2024 was $43.0.
For fiscal 2024, the Company granted short-term equity incentive compensation awards to certain associates in the form of restricted share-based award units in lieu of cash-based annual incentive awards. During the three months ended December 28, 2024, these fiscal 2024 awards representing 0.3 million Common Shares were granted and vested on the incentive payout date. The number of restricted share-based award units that the Company ultimately issued to participating associates was based on the incentive payout amount determined for each employee that was then converted into a variable number of restricted share-based award units based on the fair value of the Common Shares on the grant date.
For fiscal 2025, the Company is granting short-term equity incentive compensation awards to certain associates in the form of restricted share-based award units in lieu of cash-based annual incentive awards. The program is structured so the fiscal 2025 incentive grant, if any, will be made on or near the incentive payout date, subject to certain performance conditions and a service requirement. The number of restricted share-based award units that are ultimately issued to participating associates will be determined based on the incentive payout amount determined for each associate converted into a variable number of restricted share-based award units based on the fair value of the Common Shares on the grant date. The awards are classified as liability awards and, as of December 28, 2024, the Company had accrued $3.9 in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets associated with these awards. As of December 28, 2024, there was $17.0 of total unrecognized pre-tax compensation cost related to these nonvested restricted share-based awards that is expected to be recognized over the remainder of fiscal 2025. The units associated with these awards are excluded from the table above.
Performance-based awards
Performance-based award activity was as follows (based on target award amounts):
No. of
Units		Wtd. Avg. Grant Date
Fair Value per Unit
Awards outstanding at September 30, 2024409,430 $86.61 
Forfeited(101,680)117.78 
Awards outstanding at December 28, 2024307,750 76.96 
The weighted-average grant-date fair value of performance-based award units granted during the three months ended December 30, 2023 was $44.86 per share. As of December 28, 2024, there was $4.9 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based award units that is expected to be recognized over a weighted-average period of 1.9 years. The total fair value of performance-based award units vested during the three months ended December 30, 2023 was $10.6.